Leslie E. Grayson

654 total citations
25 papers, 423 citations indexed

About

Leslie E. Grayson is a scholar working on Psychiatry and Mental health, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, Leslie E. Grayson has authored 25 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 11 papers in Pharmacology and 6 papers in Cognitive Neuroscience. Recurrent topics in Leslie E. Grayson's work include Epilepsy research and treatment (14 papers), Cannabis and Cannabinoid Research (11 papers) and Psychosomatic Disorders and Their Treatments (7 papers). Leslie E. Grayson is often cited by papers focused on Epilepsy research and treatment (14 papers), Cannabis and Cannabinoid Research (11 papers) and Psychosomatic Disorders and Their Treatments (7 papers). Leslie E. Grayson collaborates with scholars based in United States. Leslie E. Grayson's co-authors include Jerzy P. Szaflarski, Tyler E. Gaston, Steve Ampah, Kathleen Hernando, E. Martina Bebin, Gary Cutter, E. Martina Bebin, Jane B. Allendorfer, Rodolphe Nenert and James T Houston and has published in prestigious journals such as Annals of Neurology, Epilepsia and Clinical Pharmacology & Therapeutics.

In The Last Decade

Leslie E. Grayson

22 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leslie E. Grayson United States 12 291 225 123 79 42 25 423
Eric Segal United States 12 167 0.6× 310 1.4× 151 1.2× 47 0.6× 189 4.5× 38 534
Robert Flamini United States 12 496 1.7× 584 2.6× 323 2.6× 83 1.1× 310 7.4× 21 957
Wilson Luíz Sanvito Brazil 7 376 1.3× 183 0.8× 192 1.6× 95 1.2× 25 0.6× 42 586
Johan Szamosi Sweden 13 333 1.1× 334 1.5× 48 0.4× 52 0.7× 18 0.4× 38 684
Elena Kornyeyeva United States 5 261 0.9× 53 0.2× 67 0.5× 57 0.7× 47 1.1× 5 459
C. Bountra United Kingdom 6 204 0.7× 37 0.2× 214 1.7× 55 0.7× 28 0.7× 18 570
Hana Florian United States 8 256 0.9× 219 1.0× 50 0.4× 97 1.2× 19 0.5× 20 502
Bola Tayo United Kingdom 10 673 2.3× 167 0.7× 125 1.0× 62 0.8× 88 2.1× 12 750
J.L. Pinquier France 9 223 0.8× 52 0.2× 126 1.0× 73 0.9× 29 0.7× 16 392
Peter T. Doohan Australia 9 320 1.1× 101 0.4× 132 1.1× 46 0.6× 28 0.7× 12 378

Countries citing papers authored by Leslie E. Grayson

Since Specialization
Citations

This map shows the geographic impact of Leslie E. Grayson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie E. Grayson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie E. Grayson more than expected).

Fields of papers citing papers by Leslie E. Grayson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie E. Grayson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie E. Grayson. The network helps show where Leslie E. Grayson may publish in the future.

Co-authorship network of co-authors of Leslie E. Grayson

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie E. Grayson. A scholar is included among the top collaborators of Leslie E. Grayson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie E. Grayson. Leslie E. Grayson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szaflarski, Jerzy P., W. Curt LaFrance, Rodolphe Nenert, et al.. (2025). Neurobehavioral therapy in functional seizures: Investigation of mechanism of action with resting‐state functional magnetic resonance imaging. Epilepsia. 66(8). 2881–2893. 1 indexed citations
2.
Allendorfer, Jane B., Stephen Correia, Tyler E. Gaston, et al.. (2025). Neuroplastic changes in patients with functional seizures following neurobehavioral therapy. NeuroImage Clinical. 46. 103774–103774. 1 indexed citations
3.
Patten, Ryan Van, Andrew S. Blum, Stephen Correia, et al.. (2024). One‐year follow‐up of neurobehavioral therapy in functional seizures or epilepsy with traumatic brain injury: A nonrandomized controlled trial. Epilepsia. 65(12). 3545–3560. 5 indexed citations
4.
Patten, Ryan Van, Kristen Mordecai, Hamada Altalib, et al.. (2023). Improvements in Montreal Cognitive Assessment scores after neurobehavioral therapy in adults with functional (nonepileptic) seizures and traumatic brain injury. Journal of Psychiatric Research. 165. 282–289. 5 indexed citations
5.
Mueller, Christina, Adam M. Goodman, Jane B. Allendorfer, et al.. (2023). White Matter Changes after Neurobehavioral Therapy for Functional Seizures. Annals of Neurology. 94(2). 350–365. 12 indexed citations
6.
7.
Yang, Edward, Camilo Jaimes, Anna K. Prohl, et al.. (2022). Limited utility of structural MRI to identify the epileptogenic zone in young children with tuberous sclerosis. Journal of Neuroimaging. 32(5). 991–1000. 4 indexed citations
8.
Gaston, Tyler E., Steve Ampah, E. Martina Bebin, et al.. (2021). Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsy. Epilepsy & Behavior. 117. 107862–107862. 30 indexed citations
9.
Grayson, Leslie E., Steve Ampah, Kathleen Hernando, et al.. (2021). Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsy. Epilepsy & Behavior. 122. 108190–108190. 11 indexed citations
10.
Goodman, Adam M., Jane B. Allendorfer, Andrew S. Blum, et al.. (2020). White matter and neurite morphology differ in psychogenic nonepileptic seizures. Annals of Clinical and Translational Neurology. 7(10). 1973–1984. 28 indexed citations
11.
Gaston, Tyler E., Jane B. Allendorfer, E. Martina Bebin, et al.. (2020). Effects of highly purified cannabidiol (CBD) on fMRI of working memory in treatment-resistant epilepsy. Epilepsy & Behavior. 112. 107358–107358. 11 indexed citations
12.
Nenert, Rodolphe, Jane B. Allendorfer, E. Martina Bebin, et al.. (2020). Cannabidiol normalizes resting-state functional connectivity in treatment-resistant epilepsy. Epilepsy & Behavior. 112. 107297–107297. 24 indexed citations
13.
Martin, Roy C., Leslie E. Grayson, Steve Ampah, et al.. (2020). Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsy. Epilepsy & Behavior. 111. 107299–107299. 27 indexed citations
14.
Gaston, Tyler E., E. Martina Bebin, Gary Cutter, et al.. (2019). Drug–drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access Program. Epilepsy & Behavior. 98(Pt A). 201–206. 35 indexed citations
15.
Allendorfer, Jane B., Rodolphe Nenert, E. Martina Bebin, et al.. (2019). fMRI study of cannabidiol-induced changes in attention control in treatment-resistant epilepsy. Epilepsy & Behavior. 96. 114–121. 32 indexed citations
16.
Szaflarski, Jerzy P., Kathleen Hernando, E. Martina Bebin, et al.. (2019). Higher cannabidiol plasma levels are associated with better seizure response following treatment with a pharmaceutical grade cannabidiol. Epilepsy & Behavior. 95. 131–136. 42 indexed citations
17.
Nenert, Rodolphe, Jane B. Allendorfer, Tyler E. Gaston, et al.. (2019). A preliminary study of the effects of cannabidiol (CBD) on brain structure in patients with epilepsy. Epilepsy & Behavior Reports. 12. 100341–100341. 11 indexed citations
18.
Grayson, Leslie E. & Jennifer DeWolfe. (2018). Sleep Disorders in Epilepsy: Current Trends and Future Perspectives. Current Sleep Medicine Reports. 4(2). 125–133. 4 indexed citations
19.
Grayson, Leslie E., et al.. (2017). An interaction between warfarin and cannabidiol, a case report. Epilepsy & Behavior Case Reports. 9. 10–11. 92 indexed citations
20.
Grayson, Leslie E.. (1974). The Promotion of Indigenous Private Enterprise in Ghana. Journal of Asian and African Studies. 9(1-2). 17–28. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Segal Breakdown of academic impact, for papers by Robert Flamini Breakdown of academic impact, for papers by Wilson Luíz Sanvito Breakdown of academic impact, for papers by Johan Szamosi Breakdown of academic impact, for papers by Elena Kornyeyeva Breakdown of academic impact, for papers by C. Bountra Breakdown of academic impact, for papers by Hana Florian Breakdown of academic impact, for papers by Bola Tayo Breakdown of academic impact, for papers by J.L. Pinquier Breakdown of academic impact, for papers by Peter T. Doohan
Rankless by CCL
2026